Peter Libby and Team Reveal Causal Proteomic Links in Clonal Hematopoiesis
Peter Libby, Mallinckrodt Professor of Medicine and Cardiovascular Specialist at Harvard Medical School and Brigham and Women’s Hospital, posted on LinkedIn:
”Causal Proteomic Consequences of Clonal Hematopoiesis: Integrated Human Genetic and Murine Validation
Zhi Yu, Amelie Vromman…Art Schuermans…Thiago Rentz Ferreira Laginski… Abhishek Niroula…Michael C. Honigberg, Amy E. Lin …Sara Haidermota…Benjamin Ebert…Alexander G. Bick, Siddhartha Jaiswal, Robert E. Gerszten, Peter Libby, Rajat Gupta, Pradeep Natarajan
Presented elegantly today at AHA New Orleans by Zhi Yu, the results of an amazing collaboration on CHIP proteomics that provide new insights and generate novel mechanistic hypotheses regarding the manifold clinical consequences of this newly recognized risk factor.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
-
Jan 12, 2026, 01:45Khurram Nasir on Where The Cholesterol Guidelines Are Headed